KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Cash from Investing Activities (2017 - 2025)

Alnylam Pharmaceuticals' Cash from Investing Activities history spans 17 years, with the latest figure at -$37.2 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 29.76% year-over-year to -$37.2 million; the TTM value through Dec 2025 reached $436.3 million, up 473.44%, while the annual FY2025 figure was $436.3 million, 473.44% up from the prior year.
  • Cash from Investing Activities reached -$37.2 million in Q4 2025 per ALNY's latest filing, down from $501.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $501.1 million in Q3 2025 to a low of -$413.4 million in Q4 2021.
  • Average Cash from Investing Activities over 5 years is -$6.0 million, with a median of -$33.7 million recorded in 2024.
  • Peak YoY movement for Cash from Investing Activities: plummeted 775.01% in 2021, then skyrocketed 1756.55% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$413.4 million in 2021, then surged by 66.16% to -$139.9 million in 2022, then tumbled by 72.01% to -$240.7 million in 2023, then soared by 78.01% to -$52.9 million in 2024, then grew by 29.76% to -$37.2 million in 2025.
  • Per Business Quant, the three most recent readings for ALNY's Cash from Investing Activities are -$37.2 million (Q4 2025), $501.1 million (Q3 2025), and -$141.4 million (Q2 2025).